LSB Medical Technology Holding Group and SafeWell Group Strengthen Strategic Partnership for the Production of Medical Technology

LSB MedTech Holding Group Ltd, a leading global player in medical technology and biomedical engineering, announces a strategic partnership with SafeWell Group Holdings (China) Co., Ltd for the production of some of its high-quality medical products. This alliance optimizes the manufacturing process and ensures compliance with the highest international quality standards.

SafeWell Group is a global pioneer in security and industrial manufacturing. The company operates a 66,700 square-meter headquarters in the Asia-Pacific region. Additionally, it owns SafeWell Global Hub, a large-scale 120,060-square-meter facility in the Greater Economic Zone. SafeWell has manufacturing facilities in France, Germany, Turkey, the United States, the United Kingdom, and Australia, as well as a production base in Vietnam. With over 10 internationally recognized brands and strategic collaborations with Fortune Global 500 companies and security industry leaders, Safewell is committed to innovation and high-quality manufacturing.

For LSB MedTech, this partnership represents a strategic expansion of its production capabilities. With a multidisciplinary team of biomedical engineers and medical scientists, LSB MedTech specializes in the development, patenting and global licensing of cutting-edge medical technologies.

This alliance elevates the production of medical equipment to new standards, making technological innovation more accessible to professionals and patients worldwide.

FlipProne XL App: Innovative Support for Prone & Supine Therapy
The FlipProne XL App was developed by LSB MedTech to optimize the use and application of the FlipProne XL system for healthcare professionals in hospitals, nursing homes, and disability care organizations. With this advanced application, the FlipProne XL is no longer just a patient turning system but a comprehensive Prone & Supine therapy platform. The communication between the app, smart textile technology, and the system enables patients to be safely and precisely positioned in any desired posture within their own bed. The textile components of the smart sheet have undergone multiple clinical tests and scientific studies to ensure safety and effectiveness.
Prone & Supine Therapy addresses the growing need for a safer and more efficient alternative to the labor-intensive manual repositioning of patients in hospital and home care beds. The FlipProne XL, in combination with the FlipProne XL App, offers various therapeutic approaches, including:

• Prone and Supine positioning
• Prone and Supine positioning with continuous lateral rotation

Interview with MTL Metal Magazine
Production Partner Wanted for Patient Turning System
LSB MedTech, a leading medical technology company based in the UAE and Breda, is dedicated to developing innovative solutions that enhance patient care. One of its recent advancements is a sophisticated system designed to assist healthcare professionals in safely and efficiently repositioning patients in medical facilities.

The initial production series of the patient-turning system is manufactured in China. To optimize its supply chain and better serve the European market, LSB MedTech is now seeking a Dutch metal manufacturer capable of producing the FlipProne frame on a large scale.

Link to the Metal Magazine: https://www.metaalmagazine.nl/nieuws/productiepartner-gezocht-voor-patient-draaisysteem/96132/

New Address Notification

Dear Business Partners,

As previously communicated, our CRO Laboratory activities have been acquired. Consequently, we have relocated our offices from Leiden (Bio Science Park) and Eindhoven (Brainport) to Breda.
LSB MedTech Ltd (formerly Life Science Business) will continue its medical technology activities and innovation consultancy services under its new name.

Please update your records accordingly. Should you have any questions, do not hesitate to contact us.

Best regards,
LSB MedTech Group Ltd

CRO Division
Until July 2023, LSB MedTech Ltd (formerly Life Science Business Ltd) provided clinical research organization (CRO) services to pharmaceutical companies and the medical technology industry. These services included the design, execution, and analysis of clinical studies to support the development and regulatory approval of innovative pharmaceuticals and medical devices.

As of July 2023, the CRO laboratory activities have been acquired, allowing LSB MedTech to focus entirely on medical technology innovation, innovation consultancy, and intellectual property valorization.

Our Partner Aeonmed
Aeonmed operates three research and development centers located in Beijing, Shanghai, and Pennsylvania, USA. The company also has branch offices in Germany and Indonesia. Innovation is a fundamental pillar of Aeonmed’s corporate strategy and core competence.

By the end of 2016, Aeonmed had filed a total of 1,158 patents, including 747 invention patents. More than 30% of the company’s workforce is engaged in research and development. Annually, over 10% of total revenue is allocated to R&D, driving technological advancements and product innovation.

Interview with The National Zorggids
Dutch and American researchers have developed a groundbreaking bio-electronic neurodegenerative filter technology. This innovative technology has the potential to effectively block tremors in Parkinson’s patients in the future, eliminating the need for invasive brain surgery.

This research has been made possible with the support of Life Science Business, a strategic partner of Erasmus University Rotterdam.

Link to the website: https://www.nationalezorggids.nl/ziekenhuizen/nieuws/52575-parkinsontremors-blokkeren-zonder-hersenoperatie-met-nieuwe-technologie.html

ICU Fighter 2 with Smart Textile fabric
LSB MedTech introduces the ICU Fighter 2, the world’s first patented system to relieve the ICU staff of the Prone & Supine positioning of COVID-19 patients.
By using the Dutch ICU Fighter, patients can be turned within 5 minutes with the help of only 2 healthcare professionals. Deploying this system ensures that hospitals save time, fewer staff is necessary and less healthcare costs. In addition, it ensures that less physical effort is required from the hospital staff.

DNF
Our researchers have invented the revolutionary Dutch Bio-electronic Neurodegenerative Filter Technology (patented).
DNF is the first technology and system that is able to filter and block involuntary impulses (such as the Parkinson tremor) sent from the brain to the muscles in arms and/or legs, while allowing the passage of normal voluntary signals of muscle movement without brain surgery.

Thrombosis Elastic Stocking
LSB MedTech is developing biomaterials improving the effect of elastic stockings by local transdermal application of natural thrombosis-preventing compounds. This novel approach is specifically aimed for use by consumers at elevated risk for temporarily deep vein thrombosis, such as long-distance travellers who have other risk factors for thrombosis (Factor VLeiden, use of oral contraceptives, etc.).